Horizon Pharma Targets Actavis Over Generic Rayos
Swiss drugmakers Horizon Pharma AG and Jagotec AG hit Actavis Inc. with a suit in New Jersey federal court Monday, sayings its planned generic version of anti-inflammatory drug Rayos infringes several...To view the full article, register now.
Already a subscriber? Click here to view full article